Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enanta Pharmaceuticals, Inc. - Common Stock
(NQ:
ENTA
)
13.41
-0.40 (-2.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enanta Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
December 24, 2024
Via
Benzinga
Enanta Pharma Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
December 24, 2024
Via
Benzinga
Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
December 24, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)
December 09, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
4 Analysts Assess Enanta Pharma: What You Need To Know
↗
November 26, 2024
Via
Benzinga
Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)
December 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharma Earnings Analysis: Q4 Recap
↗
November 25, 2024
Via
Benzinga
Enanta Pharma Q4 Earnings Assessment
↗
November 25, 2024
Via
Benzinga
Insights into Enanta Pharma Q4 Earnings
↗
November 25, 2024
Via
Benzinga
Enanta Pharma: Q4 Earnings Insights
↗
November 25, 2024
Via
Benzinga
Earnings Breakdown: Enanta Pharma Q4
↗
November 25, 2024
Via
Benzinga
Enanta Pharma's Earnings Outlook
↗
November 22, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
↗
October 09, 2024
Via
Benzinga
Recap: Enanta Pharma Q1 Earnings
↗
February 07, 2024
Via
Benzinga
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024
November 25, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For November 25, 2024
↗
November 25, 2024
Via
Benzinga
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
↗
September 26, 2024
Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms while maintaining a favorable safety profile. EDP-323 offers potential as a...
Via
Benzinga
Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
September 26, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate in Investor Conferences in September
September 03, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024
↗
August 05, 2024
ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
August 05, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
May 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
May 07, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024
↗
May 06, 2024
ENTA stock results show that Enanta Pharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
May 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
April 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
April 17, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
March 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
